AJP - Regu Information on EB 2010
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH
 QUICK SEARCH:   [advanced]


     


Am J Physiol Regul Integr Comp Physiol (November 3, 2005). doi:10.1152/ajpregu.00487.2005
This Article
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
290/3/R749    most recent
00487.2005v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Briz, O.
Right arrow Articles by Marin, J. J. G
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Briz, O.
Right arrow Articles by Marin, J. J. G
Submitted on July 6, 2005
Accepted on October 27, 2005

Excretion of fetal biliverdin by the rat placenta-maternal liver tandem

Oscar Briz1, Rocio I. R Macias1, Maria J Perez2, Maria A Serrano3, and Jose J. G Marin1*

1 Physiology and Pharmacology, University of Salamanca, Salamanca, Spain
2 Research Unit, University Hospital, University of Salamanca, Salamanca, Spain
3 Biochemistry and Molecular Biology, University of Salamanca, Salamanca, Spain

* To whom correspondence should be addressed. E-mail: jjgmarin{at}usal.es.

Fetal liver immaturity is accompanied by active heme catabolism. Thus fetal biliary pigments must be excreted toward the mother by the placenta. To investigate biliverdin handling by the placenta-maternal liver tandem, biliverdin-IX{alpha} was administered to 21-day pregnant rats through the jugular vein or the umbilical artery of an "in situ" perfused placenta. Jugular administration resulted in the secretion into maternal bile of both bilirubin and biliverdin (3:1). However, when biliverdin was administered to the placenta, most of it was transformed into bilirubin before being transferred to the maternal blood. Injecting Xenopus laevis oocytes with mRNA from rat liver or placenta enhanced their ability to take up biliverdin, which was inhibited by estradiol 17{beta}-D-glucuronide. The expression of three Oatp isoforms in this system revealed that they have different ability to transport biliverdin (Oatp1/1a1>Oatp2/1a4>Oatp4/1b2). The abundance of their mRNA in rat trophoblast was Oatp1/1a1>>Oatp4/1b2>Oatp2/1a4. The expression of biliverdin-IX{alpha} reductase in rat placenta was detected by RT-PCR/sequencing and Western blot. The relative abundance of biliverdin-IX{alpha} reductase mRNA (determined by real-time quantitative RT-PCR) was fetal liver>placenta>maternal liver. Common bile duct ligation in the last week of pregnancy induced an up-regulation of biliverdin-IX{alpha} reductase in maternal liver, but had no effect on fetal liver and placenta. In conclusion, several members of the Oatp family may contribute to the uptake of fetal biliverdin by the rat placenta. Prior to being transferred to the mother, biliverdin is extensively converted into bilirubin by biliverdin-IX{alpha} reductase, whose expression is maintained even though bilirubin excretion into maternal bile is impaired.







HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH
Visit Other APS Journals Online
Copyright © 2005 by the American Physiological Society.